LNCaP公司
二氢睾酮
雄激素受体
前列腺癌
基因敲除
前列腺
生物
癌症研究
内分泌学
免疫染色
雄激素
内科学
化学
细胞培养
癌症
医学
免疫组织化学
激素
遗传学
作者
Naoki Harada,Toshiki Takagi,Yoshihisa Nakano,Ryoichi Yamaji,Hiroshi Inui
标识
DOI:10.1080/09168451.2015.1025035
摘要
Abstract Androgen receptor (AR) signaling is the master regulator of prostate cell growth. Here, to better understand AR signaling, we searched for AR-interacting proteins by yeast two-hybrid screening and identified protein arginine methyltransferase 10 (PRMT10) as one of the interacting proteins. PRMT10 was highly expressed in reproductive tissues, such as prostate. Immunostaining showed that PRMT10 was expressed in the nucleus of both epithelia and stroma of rat prostate. In human prostate cancer LNCaP cells, PRMT10 co-immunoprecipitated with AR in both the presence and absence of dihydrotestosterone (DHT). Knockdown of PRMT10 by siRNA decreased DHT-dependent LNCaP cell growth and induction of prostate-specific antigen, an AR-target gene, without apparent loss of AR. DHT decreased PRMT10 at both the mRNA and protein levels. The decrease in PRMT10 was canceled by knockdown of AR or an AR antagonist. These results indicate that PRMT10 plays an important role in androgen-dependent proliferation of prostate cancer cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI